Autoimmunity to Gephyrin in Stiff-Man Syndrome
Open Access
- 1 May 2000
- Vol. 26 (2) , 307-312
- https://doi.org/10.1016/s0896-6273(00)81165-4
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (CA-46128, DK-45735, DK-53015)
This publication has 42 references indexed in Scilit:
- The Importance of Defining the Paraneoplastic Neurologic DisordersNew England Journal of Medicine, 1999
- Paraneoplastic SyndromesArchives of Neurology, 1999
- Gephyrin, a major player in GABAergic postsynaptic membrane assembly?Nature Neuroscience, 1998
- Tumor-specific killer cells in paraneoplastic cerebellar degenerationNature Medicine, 1998
- Hyperekplexia: abnormal startle response due to glycine receptor mutationsThe British Journal of Psychiatry, 1997
- A role of amphiphysin in synaptic vesicle endocytosis suggested by its binding to dynamin in nerve terminals.Proceedings of the National Academy of Sciences, 1996
- Autoimmunity in Stiff‐Man Syndrome with breast cancer is targeted to the C‐terminal region of human amphiphysin, a protein similar to the yeast proteins, Rvs167 and Rvs161FEBS Letters, 1994
- Stiff‐person syndrome: An autoimmune diseaseMovement Disorders, 1991
- Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylaseNature, 1990
- Synapsin I (protein I), a nerve terminal-specific phosphoprotein. I. Its general distribution in synapses of the central and peripheral nervous system demonstrated by immunofluorescence in frozen and plastic sections.The Journal of cell biology, 1983